HarrietteLynnStarrMD

PubMed

• 4 citations
  Self-reported review of the value of esketamine in patients with treatment-resistant depression: Understanding the patient experience in the STRIVE Study
  H. Lynn Starr, Jill Abell, Allyson Larish, Sandy Lewis, Carla DeMuro, Jagadish Gogate, Carol Jamieson, Naim Zaki, Michelle Kramer> ;Psychiatry Research. 2020 Nov 1
• Treatment effect with paliperidone palmitate compared with oral antipsychotics in patients with recent-onset versus more chronic schizophrenia and a history of crimina...
  Alphs, L.,Bossie, C.,Mao, L.,Lee, E.,Starr, H. L.> ;Early Interv Psychiatry. 2015 Sep 26
• 20 citations
  Comparison of long-acting and oral antipsychotic treatment effects in patients with schizophrenia, comorbid substance abuse, and a history of recent incarceration: An ...
  H. Lynn Starr, Jason Bermak, Lian Mao, Steve Rodriguez, Larry Alphs> ;Schizophrenia Research. 2017 Jun 7
• 21 citations
  Randomized, 6-Week, Placebo-Controlled Study of Treatment for Adult Attention-Deficit/Hyperactivity Disorder: Individualized Dosing of Osmotic-Release Oral System (ORO...
  David W. Goodman, H. Lynn Starr, Yi Wen Ma, Anthony L. Rostain, Steve Ascher, Robert B. Armstrong> ;The Journal of Clinical Psychiatry. 2017 Jan 25
• Real-world outcomes of paliperidone palmitate compared to daily oral antipsychotic therapy in schizophrenia: a randomized, open-label, review board-blinded 15-month st...
  Alphs L, Benson C, Cheshire-Kinney K, Lindenmayer J, Mao L, Rodriguez SC, Starr HL> ;J Clin Psychiatry. 2015-05-01
• Design and rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) study: a novel comparative trial of once-monthly paliperidone palmit...
  Alphs, L.,Mao, L.,Rodriguez, S. C.,Hulihan, J.,Starr, H. L.> ;J Clin Psychiatry. 2014 Nov 07
• Join now to see all